Vaccines for E B v and M S

Results from a huge epidemiological study found that infection by the Epstein-Barr virus increases the risk of developing multiple sclerosis 32-fold. This result, combined with emerging mechanistic insights into how the virus triggers brain damage, are raising the prospect of treating or preventing MS.

These advances come at a time when researchers are more interested than ever in what happens in the months and years following a viral infection, and highlights the issues untangling the relationships between infectious diseases and chronic conditions.

This is an audio version of our Feature: The quest to prevent MS — and understand other post-viral diseases.

Hosted on Acast. See acast.com/privacy for more information.